Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • bzotter
    Junior Member
    • Mar 2015
    • 1

    #1

    Include heterochromatin in genome size estimates?

    I am planning on sequencing several entire drosophila (fruit fly) genomes for an upcoming project. The published length of the drosophila genome is ~150 Mbp, up to ~175 Mbp including known heterochromatin. However, there is supposedly another 25-50 Mbp of heterochromatin in the form of large peri-centromeric and per-telomeric DNA satellites that is not included in these estimates.

    My question is, how much does heterochromatin factor in to coverage calculations for NGS? When I am calculating my estimated genome coverage and figuring out how many lanes we need, should I be using 150 Mbp (eurchromatin only) or ~200 Mbp (euchromatin+heterochromatin)? I know that large tandem repeats and "structural" DNA (i.e. satellites) will not be properly amplified or sequenced, but I'm assuming they will still consume reagents and take up some space in the lane. Any advice you can provide would be much appreciated.

    The sequencing will be done on an illumina HiSeq 2500, most likely using 2*100 bp reads.

    Thanks,
    Brendan

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
68 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...